What is LOPJLB’s current signal on DYN?

LOPJLB’s latest quantitative signal on Dyne Therapeutics, Inc. (DYN) is SELL in a RECOVERY regime. Signals are updated daily.

What market regime is DYN in?

Dyne Therapeutics, Inc. (DYN) is currently classified in the RECOVERY HMM market regime on LOPJLB.

What does Dyne Therapeutics, Inc. (DYN) do?

Dyne Therapeutics, Inc. is a U.S.-based biotechnology firm focused on developing advanced treatments for genetically driven muscle disorders. Utilizing its proprietary FORCE platform, which is engineered to deliver disease-modifying therapeutics, the company is actively engaged in various programs. These initiatives target conditions such as myotonic dystrophy type 1, Duchenne muscular dystroph…

Where is Dyne Therapeutics, Inc. based / listed?

Dyne Therapeutics, Inc. is based in US, listed on NASDAQ.

Dyne Therapeutics, Inc. (DYN)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$16.37+2.50%Close

SELLRECOVERY · day 1

[SCORES & PROFILE]

FUND: 19
VALUE: 8
GROWTH: 47
GARP: 6
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-38.6%

REV YoY-

ROE-64.3%

EPS YoY-

ROA-52.3%

GROSS

NET

[VALUATION]

P/E TTM-4.62

P/E FWD-

SECTOR PE20.12

INDUSTRY PE13.79

P/B3.63

P/FCF-

EV/EBITDA-4.48

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E2.83

ALTMAN Z-

CURR RATIO12.02

ND/EBITDA-

BETA1.12

Dyne Therapeutics, Inc. (DYN)

Key stats

Industry peers

Prediction markets

FUNDAMENTALS

Company news